Advertisement

Biotechnology Letters

, Volume 40, Issue 5, pp 755–763 | Cite as

Hepatic esterase activity is increased in hepatocyte-like cells derived from human embryonic stem cells using a 3D culture system

  • Young-Jun Choi
  • Hyemin Kim
  • Ji-Woo Kim
  • Seokjoo Yoon
  • Han-Jin Park
Original Research Paper
  • 278 Downloads

Abstract

Objectives

The aim of the study is to generate a spherical three-dimensional (3D) aggregate of hepatocyte-like cells (HLCs) differentiated from human embryonic stem cells and to investigate the effect of the 3D environment on hepatic maturation and drug metabolism.

Results

Quantitative real-time PCR analysis indicated that gene expression of mature hepatocyte markers, drug-metabolizing enzymes, and hepatic transporters was significantly higher in HLCs cultured in the 3D system than in those cultured in a two-dimensional system (p < 0.001). Moreover, hepatocyte-specific functions, including albumin secretion and bile canaliculi formation, were increased in HLCs cultured in the 3D system. In particular, 3D spheroidal culture increased expression of CES1 and BCHE, which encode hepatic esterases (p < 0.001). The enhanced activities of these hepatic esterases were confirmed by the cholinesterase activity assay and the increased susceptibility of HLCs to oseltamivir, which is metabolized by CES1.

Conclusions

3D spheroidal culture enhances the maturation and drug metabolism of stem cell-derived HLCs, and this may help to optimize hepatic differentiation protocols for hepatotoxicity testing.

Keywords

Human embryonic stem cell 3D culture Hepatic maturation Hepatic esterases Drug transporters 

Notes

Acknowledgements

The authors would like to thank the CHA Stem Cell Institute (CHA University, Korea) for providing the CHA-hES15 cell line. This work was funded by the Basic Science Research Program through National Research Foundation (NRF) funding from the Ministry of Science and ICT, Republic of Korea (No. NRF-2017R1C1B2010444).

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

References

  1. Aleksunes LM, Augustine LM, Cherrington NJ, Manautou JE (2007) Influence of acetaminophen vehicle on regulation of transporter gene expression during hepatotoxicity. J Toxicol Environ Health A 70:1870–1872CrossRefPubMedGoogle Scholar
  2. Baharvand H, Hashemi SM, Ashtiani SK, Farrokhi A (2006) Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. Int J Dev Biol 50:645–652CrossRefPubMedGoogle Scholar
  3. Bell CC, Hendriks DFG, Moro SML, Elis E et al (2016) Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep 6:25187CrossRefPubMedCentralPubMedGoogle Scholar
  4. Bierwolf J, Lutgehetmann M, Feng K, Erbes J, Deichmann S, Toronyi E, Stieglitz C, Nashan B, Ma PX, Pollok JM et al (2011) Primary rat hepatocyte culture on 3D nanofibrous polymer scaffolds for toxicology and pharmaceutical research. Biotechnol Bioeng 108:141–150CrossRefPubMedGoogle Scholar
  5. Cai J, Zhao Y, Liu Y, Ye F et al (2007) Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 45:1229–1239CrossRefPubMedGoogle Scholar
  6. Casey Laizure S, Herring V, Hu Z, Witbrodt K, Parker RB (2013) The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Pharmacotherapy 33:210–222CrossRefPubMedGoogle Scholar
  7. Davies BE (2010) Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations. J Antimicrob Chemother 65(Suppl 2):5–10Google Scholar
  8. Davila JC, Cezar GG, Thiede M, Strom S, Miki T, Trosko J (2004) Use and application of stem cells in toxicology. Toxicol Sci 79:214–223CrossRefPubMedGoogle Scholar
  9. Dimov D, Kanev K, Dimova I (2012) Correlation between butyrylcholinesterase variants and sensitivity to soman toxicity. Acta Biochim Pol 59:313–316PubMedGoogle Scholar
  10. Fukami T, Yokoi T (2012) The emerging role of human esterases. Drug Metab Pharmacokinet 27:466–477CrossRefPubMedGoogle Scholar
  11. Gieseck RL, Hannan NRF, Bort R, Hanley NA, Drake RAL, Cameron GWW, Wynn TA, Vallier L (2014) Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture. PLoS ONE 9:e86372CrossRefPubMedGoogle Scholar
  12. Godoy P, Hewitt NJ, Albrecht U, Andersen ME et al (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87:1315–1530CrossRefPubMedCentralPubMedGoogle Scholar
  13. Hook LA (2012) Stem cell technology for drug discovery and development. Drug Discov Today 17:336–342CrossRefPubMedGoogle Scholar
  14. Justice BA, Badr NA, Felder RA (2009) 3D cell culture opens new dimensions in cell-based assays. Drug Discov Today 14:102–107CrossRefPubMedGoogle Scholar
  15. Laupèze B, Amiot L, Payen L, Drenou B, Grosset JM, Lehne G, Fauchet R, Fardel O (2001) Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood. Life Sci 68:1323–1331CrossRefPubMedGoogle Scholar
  16. Lee JE, Kang MS, Park MH, Shim SH, Yonn TK, Chung HM, Lee DR (2010) Evaluation of 28 human embryonic stem cell lines for use as unrelated donors in stem cell therapy: implications of HLA and ABO genotypes. Cell Transplant 19:1383–1395CrossRefPubMedGoogle Scholar
  17. Nagamoto Y, Tashiro K, Takayama K, Ohashi K, Kawabata K, Sakurai F, Tachibana M, Hayakawa T, Furue MK, Mizuguchi H (2012) The promotion of hepatic maturation of human pluripotent stem cells in 3D co-culture using type I collagen and Swiss 3T3 cell sheets. Biomaterials 33:4526–4534CrossRefPubMedGoogle Scholar
  18. Ogawa S, Surapisitchat J, Virtanen C, Ogawa M et al (2013) Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development 140:3285–3296CrossRefPubMedCentralPubMedGoogle Scholar
  19. Pampaloni F, Reynaud EG, Stelzer EHK (2007) The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8:839–845CrossRefPubMedGoogle Scholar
  20. Park H-J, Choi Y-J, Kim JW, Chun HS, Im I, Yoo S, Han Y-M, Song C-W, Kim H (2015) Differences in the epigenetic regulation of cytochrome P450 genes between human embryonic stem cell-derived hepatocytes and primary hepatocytes. PLoS ONE 10:e0132992CrossRefPubMedCentralPubMedGoogle Scholar
  21. Ramboer E, Vanhaecke T, Rogiers V, Vinken M (2013) Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters. Drug Metab Rev 45:196–217CrossRefPubMedGoogle Scholar
  22. Sancho-Bru P, Roelandt P, Narain N, Pauwelyn K, Notelaers T, Shimizu T, Ott M, Verfaillie C (2011) Directed differentiation of murine-induced pluripotent stem cells to functional hepatocyte-like cells. J Hepatol 54:98–107CrossRefPubMedGoogle Scholar
  23. Schyschka L, Sánchez JJM, Wang Z, Burkhardt B, Müller-Vieira U, Zeilinger K, Bachmann A, Nadalin S, Damm G, Nussler AK (2013) Hepatic 3D cultures but not 2D cultures preserve specific transporter activity for acetaminophen-induced hepatotoxicity. Arch Toxicol 87:1581–1593CrossRefPubMedGoogle Scholar
  24. Shi D, Yang J, Yang D, LeCluyse EL, Black C, You L, Akhlaghi F, Yan B (2006) Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel. J Pharmacol Exp Ther 319:1477–1484CrossRefPubMedGoogle Scholar
  25. Shiraki N, Umeda K, Sakashita N, Takeya M, Kume K, Kume S (2008) Differentiation of mouse and human embryonic stem cells into hepatic lineages. Genes Cells 13:731–746CrossRefPubMedGoogle Scholar
  26. Takayama K, Inamura M, Kawabata K et al (2012) Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4α transduction. Mol Ther 20:127–137CrossRefPubMedGoogle Scholar
  27. Takayama K, Kawabata K, Nagamoto Y et al (2013) 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing. Biomaterials 34:1781–1789CrossRefPubMedGoogle Scholar
  28. Williams JA, Hyland R, Jones BC et al (2004) Drug–drug interactions for UDP-glucoronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab Dispos 32:1201–1208CrossRefPubMedGoogle Scholar
  29. Yamada S, Richardson K, Tang M et al (2010) Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity. Pharmacogenomics J 10:524–536CrossRefPubMedGoogle Scholar
  30. Zaher H, Buters JT, Ward JM et al (1998) Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol Appl Pharmacol 152:193–199CrossRefPubMedGoogle Scholar
  31. Zamek-Gliszczynski MJ, Xiong H, Patel NJ et al (2003) Pharmacokinetics of 5 (and 6)-carboxy-2′,7′-dichlorofluorescein and its diacetate promoiety in the liver. J Pharmacol Exp Ther 304:801–809CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Predictive Model Research CenterKorea Institute of ToxicologyDaejeonRepublic of Korea
  2. 2.Human and Environmental Toxicology, School of EngineeringUniversity of Science and TechnologyDaejeonRepublic of Korea

Personalised recommendations